Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma von CAMACHO, Luis H, ANTONIA, Scott, RIBAS, Antoni, SOSMAN, Jeffrey, KIRKWOOD, John M, GAJEWSKI, Thomas F, REDMAN, Bruce, PAVLOV, Dmitri, BULANHAGUI, Cecile, BOZON, Viviana A, GOMEZ-NAVARRO, Jesus

Volltext

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206 von RIBAS, Antoni, CAMACHO, Luis H, SHARMA, Amarnath, GLASPY, John A, GOMEZ-NAVARRO, Jesus, LOPEZ-BERESTEIN, Gabriel, PAVLOV, Dmitri, BULANHAGUI, Cecile A, MILLHAM, Robert, COMIN-ANDUIX, Begona, REUBEN, James M, SEJA, Elisabeth, PARKER, Charla A

Volltext

Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults von Mullane, Kathleen M., Winston, Drew J., Wertheim, Michael S., Betts, Robert F., Poretz, Donald M., Camacho, Luis H., Pergam, Steven A., Mullane, Michael R., Stek, Jon E., Sterling, Tina M., Zhao, Yanli, Manoff, Susan B., Annunziato, Paula W.

Volltext

CTLA‐4 blockade with ipilimumab: biology, safety, efficacy, and future considerations von Camacho, Luis H.

Volltext

Current Status of Biosimilars in Oncology von Camacho, Luis H.

Volltext

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer von Brahmer, Julie R, Tykodi, Scott S, Chow, Laura Q.M, Hwu, Wen-Jen, Topalian, Suzanne L, Hwu, Patrick, Drake, Charles G, Camacho, Luis H, Kauh, John, Odunsi, Kunle, Pitot, Henry C, Hamid, Omid, Bhatia, Shailender, Martins, Renato, Eaton, Keith, Chen, Shuming, Salay, Theresa M, Alaparthy, Suresh, Grosso, Joseph F, Korman, Alan J, Parker, Susan M, Agrawal, Shruti, Goldberg, Stacie M, Pardoll, Drew M, Gupta, Ashok, Wigginton, Jon M

Volltext

Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease von Pawlik, Timothy M, Zorzi, Daria, Abdalla, Eddie K, Clary, Bryan M, Gershenwald, Jeffrey E, Ross, Merrick I, Aloia, Thomas A, Curley, Steven A, Camacho, Luis H, Capussotti, Lorenzo, Elias, Dominique, Vauthey, Jean-Nicolas

Volltext

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma von Comin-Anduix, Begoña, Lee, Yohan, Jalil, Jason, Algazi, Alain, de la Rocha, Pilar, Camacho, Luis H, Bozon, Viviana A, Bulanhagui, Cecile A, Seja, Elisabeth, Villanueva, Arturo, Straatsma, Bradley R, Gualberto, Antonio, Economou, James S, Glaspy, John A, Gomez-Navarro, Jesus, Ribas, Antoni

Volltext

Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab von Eroglu, Zeynep, Kim, Dae Won, Wang, Xiaoyan, Camacho, Luis H, Chmielowski, Bartosz, Seja, Elizabeth, Villanueva, Arturo, Ruchalski, Kathleen, Glaspy, John A, Kim, Kevin B, Hwu, Wen-Jen, Ribas, Antoni

Volltext

A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors von TSIMBERIDOU, Apostolia Maria, CAMACHO, Luis H, SCHWARTZ, Brian, KURZROCK, Razelle, VERSTOVSEK, Srdan, NG, Chaan, HONG, David S, UEHARA, Cynthia K, GUTIERREZ, Catalina, DARING, Shawn, STEVENS, Jan, KOMARNITSKY, Philip B

Volltext

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma von Ribas, Antoni, Camacho, Luis H, Lee, Sun Min, Hersh, Evan M, Brown, Charles K, Richards, Jon M, Rodriguez, Maria Jovie, Prieto, Victor G, Glaspy, John A, Oseguera, Denise K, Hernandez, Jackie, Villanueva, Arturo, Chmielowski, Bartosz, Mitsky, Peggie, Bercovici, Nadège, Wasserman, Ernesto, Landais, Didier, Ross, Merrick I

Volltext

Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors von Naing, Aung, Reuben, James M, Camacho, Luis H, Gao, Hui, Lee, Bang-Ning, Cohen, Evan N, Verschraegen, Claire, Stephen, Saneese, Aaron, Joann, Hong, David, Wheler, Jennifer, Kurzrock, Razelle

Volltext

A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer von Schwartzberg, Lee S, Arena, Francis P, Bienvenu, Bryan J, Kaplan, Edward H, Camacho, Luis H, Campos, Luis T, Waymack, J Paul, Tagliaferri, Mary A, Chen, Michael M, Li, Dapeng

Volltext

First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors von Keedy, Vicki L., Lenz, Heinz-Josef, Saltz, Leonard, Whisenant, Jennifer G., Berlin, Jordan D., Camacho, Luis H.

Volltext

Novel therapies targeting the immune system: CTLA4 blockade with tremelimumab (CP-675,206), a fully human monoclonal antibody von Camacho, Luis H

Volltext

Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors von Hong, David S., Garrido‐Laguna, Ignacio, Ekmekcioglu, Suhendan, Falchook, Gerald S., Naing, Aung, Wheler, Jennifer J., Fu, Siqing, Moulder, Stacy L., Piha‐Paul, Sarina, Tsimberidou, Apostolia M., Wen, YueJin, Culotta, Kirk S., Anderes, Kenna, Davis, Darren W., Liu, Wen, George, Goldy C., Camacho, Luis H., Percy Ivy, Susan, Kurzrock, Razelle

Volltext

Biosimilars 101: considerations for U.S. oncologists in clinical practice von Camacho, Luis H., Frost, Craig P., Abella, Esteban, Morrow, Phuong K., Whittaker, Sadie

Volltext

Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma von Reuben, James M., Lee, Bang‐Ning, Li, Changping, Gomez‐Navarro, Jesus, Bozon, Viviana A., Parker, Charla A., Hernandez, Ingrid M., Gutierrez, Carolina, Lopez‐Berestein, Gabriel, Camacho, Luis H.

Volltext

Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer Therapy‐Melanoma questionnaire von Cormier, Janice N., Ross, Merrick I., Gershenwald, Jeffrey E., Lee, Jeffrey E., Mansfield, Paul F., Camacho, Luis H., Kim, Kevin, Webster, Kimberly, Cella, David, Palmer, J. Lynn

Volltext

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma von Kim, Kevin B, Prieto, Victor, Joseph, Richard W, Diwan, Abdul H, Gallick, Gary E, Papadopoulos, Nicholas E, Bedikian, Agop Y, Camacho, Luis H, Hwu, Patrick, Ng, Chaan S, Wei, Wei, Johnson, Marcella M, Wittemer, Sabine M, Vardeleon, Anna, Reckeweg, Aaron, Colevas, A Dimitrios

Volltext